Oct 15, 2026 08:46AM
Oct 15, 2026 08:46AM
Sep 16, 2026 07:01AM
Sep 16, 2026 07:00AM
Aug 7, 2026 08:35AM
Jun 4, 2026 08:41AM
Jun 4, 2026 08:40AM Xenetic Biosciences, Inc. Announces That Its Collaboration Partner Received Approval From the Israeli Ministry of Health to Conduct Exploratory, Investigator Initiated Study of DNase I In Combination
Jun 1, 2026 09:03AM
Jun 1, 2026 09:02AM
May 13, 2026 08:05AM
Apr 22, 2026 09:00AM
Mar 13, 2026 08:00AM
Dec 11, 2025 05:00PM
Nov 19, 2025 08:45AM Xenetic extends Scripps Research collaboration for DNase platform
Nov 19, 2025 08:45AM
Nov 13, 2025 08:45AM
Oct 10, 2025 09:31AM
Oct 10, 2025 09:30AM
Aug 13, 2025 08:00AM
Jul 30, 2025 09:01AM
Jul 30, 2025 09:00AM Xenetic Biosciences, Inc. Announces Entry by Collaboration Partner into Clinical Study Agreement to Advance Development of DNase Platform for the Treatment of Large B Cell Lymphoma
Jul 23, 2025 08:33AM
Jul 23, 2025 08:30AM
Jul 8, 2025 09:00AM
May 14, 2025 08:05AM
Apr 10, 2025 06:38AM
Apr 9, 2025 09:15AM
Mar 26, 2025 09:03AM Xenetic Biosciences (XBIO) Announces Entry by Collaboration Partner into a Clinical Study Agreement to Advance Development of DNase Platform for the Treatment of Relapsed/Refractory Osteosarcoma and E
Mar 26, 2025 09:00AM
Mar 19, 2025 08:05AM
Mar 13, 2025 08:30AM
Feb 27, 2025 09:15AM
Dec 17, 2024 09:15AM
Dec 16, 2024 09:00AM
Dec 6, 2024 06:50AM H.C. Wainwright Reiterates Neutral Rating on Xenetic Biosciences (XBIO)
Dec 5, 2024 08:47AM
Dec 5, 2024 08:45AM
Nov 22, 2024 09:15AM
Nov 21, 2024 08:30AM
Nov 13, 2024 08:30AM
Nov 12, 2024 09:00AM
Nov 7, 2024 09:00AM Xenetic Biosciences, Inc. Extends Research and Development Collaboration with The Scripps Research Institute to Advance DNase Platform
Oct 22, 2024 08:45AM
Oct 21, 2024 05:08PM
Oct 17, 2024 08:47AM
Oct 17, 2024 08:30AM
Sep 11, 2024 09:00AM
Aug 20, 2024 06:41AM
Aug 14, 2024 08:00AM Xenetic Biosciences, Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update

470,308 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All